Chugai Pharmaceutical Co., Ltd.Tokyo Japan
Company Description
Chugai Pharmaceutical develops therapies for bone metabolism and blood disorders, cancer, infectious diseases, immune system disorders, and cardiovascular, kidney, and brain diseases. Products include Neutrogin, which treats white blood cell loss related to chemotherapy; Epogin, which treats red blood cell loss caused by chronic kidney failure; Sigmart, an antianginal agent; and Alfarol for osteoporosis. Chugai Pharmaceuticals has foreign operations in Asia, Europe, and North America through subsidiaries and branch locations. Swiss drugs group
| 1-1 Nihonbashi-Muromachi 2-Chome, Chuo-Ku | Phone: +81-3-3281-6611 | http://www.chugai-pharm.co.jp |
| Tokyo 103-8324 | Fax: +81-3-3281-2828 | 
Map This Company |
| Japan |
Try a Full Premium Subscription
Access over 85 million companies
Call (866) 443-3939 or
Prepare for your Sales call
Try a Small Business Subscription
Starting $89 per month
Chugai Pharmaceutical Co., Ltd. Rankings
| Nikkei 225 |
Executives
| 39 executives listed for Chugai Pharmaceutical Co., Ltd.'s Tokyo, Japan location. | ||
| President, CEO, COO, and Director | Osamu Nagayama | |
|---|---|---|
| Director | Abraham Cohen | |
| Director | ErichHunziker | |
Financials
| Company Type | PublicHeadquarters |
|---|---|
| Fiscal Year-End | December |
| 2011 Employees | 6,779 |
DNBiLeverage D&B's credit assessment tools to positively impact
your business. Get the scoop on Chugai Pharmaceutical Co., Ltd. now.
- Reduce risk.
- Drive greater profitability.
- Increase cash flow.
